Avecho Biotechnology Limited (ASX:AVE)

Australia flag Australia · Delayed Price · Currency is AUD
0.0110
-0.0010 (-8.33%)
Mar 10, 2026, 3:58 PM AEST
83.33%
Market Cap 44.08M
Revenue (ttm) 1.24M
Net Income (ttm) -4.42M
Shares Out 3.67B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,551,041
Average Volume 7,505,486
Open 0.0110
Previous Close 0.0120
Day's Range 0.0110 - 0.0110
52-Week Range 0.0030 - 0.0120
Beta 0.91
RSI 56.54
Earnings Date Feb 26, 2026

About Avecho Biotechnology

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. In addition, the company dev... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 15
Stock Exchange Australian Securities Exchange
Ticker Symbol AVE
Full Company Profile

Financial Performance

In 2025, Avecho Biotechnology's revenue was 1.24 million, an increase of 9.28% compared to the previous year's 1.13 million. Losses were -4.42 million, 41.5% more than in 2024.

Financial Statements

News

There is no news available yet.